Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-03-000295
Filing Date
2003-08-06
Accepted
2003-08-06 14:33:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G s13g_0805-2003sonus.txt SC 13G 8582
  Complete submission text file 0000904454-03-000295.txt   10340
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48798 | Film No.: 03825941
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ONE PALMER SQUARE PRINCETON NJ 08542
Business Address
DOMAIN PUBLIC EQUITY PARTNERS LP (Filed by) CIK: 0001219248 (see all company filings)